116 related articles for article (PubMed ID: 10474116)
1. Leukemia inhibitory factor as an intrapituitary regulator of pro-opiomelanocortin gene expression and corticotrope ontogeny.
Guignat L; Bertherat J
Eur J Endocrinol; 1999 Sep; 141(3):214-5. PubMed ID: 10474116
[No Abstract] [Full Text] [Related]
2. Paracrine interactions within the pituitary gland.
Schwartz J; Van de Pavert S; Clarke I; Rao A; Ray D; Vrana K
Ann N Y Acad Sci; 1998 May; 839():239-43. PubMed ID: 9629159
[No Abstract] [Full Text] [Related]
3. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
Bousquet C; Melmed S
J Biol Chem; 1999 Apr; 274(16):10723-30. PubMed ID: 10196143
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
Ray DW; Ren SG; Melmed S
Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
Abbud RA; Kelleher R; Melmed S
Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
[TBL] [Abstract][Full Text] [Related]
6. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
7. What's in a name or what does leukemia inhibitory factor have to do with the pituitary gland?
Reichlin S
Endocrinology; 1998 May; 139(5):2199-200. PubMed ID: 9564822
[No Abstract] [Full Text] [Related]
8. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.
Mynard V; Guignat L; Devin-Leclerc J; Bertagna X; Catelli MG
Endocrinology; 2002 Oct; 143(10):3916-24. PubMed ID: 12239103
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S
Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069
[TBL] [Abstract][Full Text] [Related]
11. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
[TBL] [Abstract][Full Text] [Related]
12. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
Akita S; Webster J; Ren SG; Takino H; Said J; Zand O; Melmed S
J Clin Invest; 1995 Mar; 95(3):1288-98. PubMed ID: 7883977
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
14. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
Chesnokova V; Auernhammer CJ; Melmed S
Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Chesnokova V; Melmed S
Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and regulation of the corticotropic pituitary cell.
Petersenn S; Schulte HM
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():10-3. PubMed ID: 11281361
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
20. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells.
Jenab S; Morris PL
Endocrinology; 1998 Apr; 139(4):1883-90. PubMed ID: 9528974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
